Talibegron
Alternative Names: ICI D 2079; SCH 417849; ZD 2079Latest Information Update: 07 Feb 2003
At a glance
- Originator AstraZeneca
- Class Small molecules
- Mechanism of Action Beta 3 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Obesity; Type 2 diabetes mellitus